Aphios Corporation
Biotech IPO & Public-Markets Experience Required
North Reading, MA (Hybrid / On-site as needed)
Clinical-Stage Biotechnology | Capital Markets | Executive Leadership
Job Code: APH-2601-01
Aphios Corporation
is a clinical-stage biotechnology company advancing differentiated nanotechnology platforms and next-generation therapeutics across oncology, neurodegenerative disease, infectious disease, and substance-use disorder.
As the company enters its
next phase of growth and capital-markets readiness , Aphios is seeking an experienced
Part-Time / Fractional Chief Financial Officer (CFO)
with
direct biotech IPO and public-company preparation experience
to work closely with the CEO and Board.
This role is designed for a senior biotech finance executive who has
successfully guided companies through IPO preparation, public-company readiness, and alternative public-market pathways , and who is interested in a
high-impact, flexible leadership engagement
rather thanوقالت full-time operating role.
Key Responsibilities:
Lead financial strategy, capital planning, and cash-flow management for a growth-stage biotech
Prepare the company for
IPO and public-company readiness , including internal controls, reporting infrastructure, and governance
Oversee GAAP-compliant financial reporting, audit readiness, ಅಭ risk management
Develop and maintain long-range financial models aligned with clinical, regulatory, and commercialization milestones
Support
investor relations , Board communications, and external stakeholder engagement
Structure and evaluate
PIPE financings, crossover fund participation, and late-stage private capital strategies
Advise on
NASDAQ and NYSE uplisting requirements Bene ?
and readiness timelines
Evaluate
SPAC or de-SPAC-adjacent opportunities , as appropriate, without over-engineering the business
Interface with investment banks, auditors, securities counsel, and regulatory advisors
Oversee grant accounting and compliance (e.g., NIH, SBIR/STTR)
Qualifications:
Bachelor’s degree in Finance, Accounting, or related field (MBA, CPA, or CFA strongly preferred)
10–15+ years of senior financial leadership experience
in biotechnology or life sciences
Demonstrated experience taking a biotech company through IPO or IPO readiness
Strong working knowledge of
SEC reporting, GAAP, internal controls, and audit processes
Experience with
venture-backed, clinical-stage, or R&D-intensive organizations
Familiarity with
PIPEs, crossover investors, and public-market capital strategy
group?
Executive presence with the ability to engage effectively at the
Board and investor level
Comfortable operating in
lean, entrepreneurial environments
Why This Role?
High-impact executive position with
direct influence on capital-markets strategy
Flexible, part-time / fractional engagement suitable for seasoned CFOs
Opportunity to help position a differentiated biotech platform for
public-market execution
Mission-driven company with strong ESG alignment and meaningful therapeutic ambition
To Apply: Qualified candidates (or trusted referrals) should send a
resume and brief cover note
referencing
Job Code: APH-2601-01
to:
mail@aphios.com
www.aphios.com
No phone calls, please. Aphios Corporation is an equal opportunity employer.
#J-18808-Ljbffr
North Reading, MA (Hybrid / On-site as needed)
Clinical-Stage Biotechnology | Capital Markets | Executive Leadership
Job Code: APH-2601-01
Aphios Corporation
is a clinical-stage biotechnology company advancing differentiated nanotechnology platforms and next-generation therapeutics across oncology, neurodegenerative disease, infectious disease, and substance-use disorder.
As the company enters its
next phase of growth and capital-markets readiness , Aphios is seeking an experienced
Part-Time / Fractional Chief Financial Officer (CFO)
with
direct biotech IPO and public-company preparation experience
to work closely with the CEO and Board.
This role is designed for a senior biotech finance executive who has
successfully guided companies through IPO preparation, public-company readiness, and alternative public-market pathways , and who is interested in a
high-impact, flexible leadership engagement
rather thanوقالت full-time operating role.
Key Responsibilities:
Lead financial strategy, capital planning, and cash-flow management for a growth-stage biotech
Prepare the company for
IPO and public-company readiness , including internal controls, reporting infrastructure, and governance
Oversee GAAP-compliant financial reporting, audit readiness, ಅಭ risk management
Develop and maintain long-range financial models aligned with clinical, regulatory, and commercialization milestones
Support
investor relations , Board communications, and external stakeholder engagement
Structure and evaluate
PIPE financings, crossover fund participation, and late-stage private capital strategies
Advise on
NASDAQ and NYSE uplisting requirements Bene ?
and readiness timelines
Evaluate
SPAC or de-SPAC-adjacent opportunities , as appropriate, without over-engineering the business
Interface with investment banks, auditors, securities counsel, and regulatory advisors
Oversee grant accounting and compliance (e.g., NIH, SBIR/STTR)
Qualifications:
Bachelor’s degree in Finance, Accounting, or related field (MBA, CPA, or CFA strongly preferred)
10–15+ years of senior financial leadership experience
in biotechnology or life sciences
Demonstrated experience taking a biotech company through IPO or IPO readiness
Strong working knowledge of
SEC reporting, GAAP, internal controls, and audit processes
Experience with
venture-backed, clinical-stage, or R&D-intensive organizations
Familiarity with
PIPEs, crossover investors, and public-market capital strategy
group?
Executive presence with the ability to engage effectively at the
Board and investor level
Comfortable operating in
lean, entrepreneurial environments
Why This Role?
High-impact executive position with
direct influence on capital-markets strategy
Flexible, part-time / fractional engagement suitable for seasoned CFOs
Opportunity to help position a differentiated biotech platform for
public-market execution
Mission-driven company with strong ESG alignment and meaningful therapeutic ambition
To Apply: Qualified candidates (or trusted referrals) should send a
resume and brief cover note
referencing
Job Code: APH-2601-01
to:
mail@aphios.com
www.aphios.com
No phone calls, please. Aphios Corporation is an equal opportunity employer.
#J-18808-Ljbffr